Three strikes for Bayer as alfimeprase trials fail
Three failed clinical trials on two different drug candidates in a week are bad enough for Bayer but it is their collaborators who are really suffering.
Archives for December 13, 2006
Solvay reinforces outsourcing relationship with Lonza
Lonza Group and Solvay Pharmaceuticals have today announced a strategic long-term manufacturing alliance.
Roche invests in new 'molecular machete' drug delivery enhancer
Roche has invested $20m in a new technology that has the potential to dramatically enhance the delivery of subcutaneous drugs by acting like a 'molecular machete'.
GSK to partner EPIX in search for potential Alzheimer's treatments
Sufferers of Alzheimer's have received a boost with the news that GlaxoSmithKine has ploughed further investment into developing new drugs to combat the disease.
Merck bids for cholesterol market leadership
Merck will file for approval of a promising new cholesterol-lowerting drug in a bid to wrestle control of the cholesterol market away from Pfizer.
UK drug development needs new path
According to a review of public healthcare funding, the current method of developing drugs is unsustainable and must be updated if the UK is to remain at the forefront of European bioscience.
AstraZeneca opens first manufacturing plant in the Middle East
Pharmaceutical giant AstraZeneca has invested in a tablet manufacturing plant in Egypt, which could form a launching pad for an expansion into emerging markets.
Primate research backed by UK experts
British scientists have supported the use of primates in medical research, but only if no alternatives are available.
Schwarz awards contract for new Irish API manufacturing facility
Schwarz Pharma has awarded an engineering and procurement contract to a Jacobs Engineering Group subsidiary for the development of a new active pharmaceutical ingredient (API) manufacturing facility in Ireland.
India first choice for knowledge process outsourcing
India is the first choice for foreign companies looking to offshore their knowledge process outsourcing (KPO) activities and future growth will be fuelled by the pharma market, according to a new report.
i3 announces 4-continent expansion
i3 has announced new plans to expand its pharmaceutical services offerings across four continents - India, Latin America, and Eastern and Western Europe.